chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, Fever, NauseaVomiting, body aches, chills, back pain, swollen lymph nodes Narrative: PT REPORTED body aches, fever, chills, back pain, nausea, h/a, swollen lymph nodes AFTER 2ND COVID VACCINE DOSE. PT TREATED WITH TYLENOL.
Uncontrollable crying per mom report. About 2 cm swelling/lump to (R) upper lateral thigh. Ice pack and OTC Ibuprofen with instructions to return to clinic in AM if not better.
Hives, redness, and swelling in right upper arm 8 days after receiving first dose of Moderna Covid-19 vaccine.
After receiving the vaccine, I was really tired and had common vaccine symptoms. I had developed bell's palsy. I did a telephone call with the doctor. The doctor prescribed me a steroid for it. I used over the counter  lubricated eye drops to help with it as well.
This spontaneous case, initially received on 30-Aug-2018, reported by other health professional (nurse), concerning a 6-months-old, female infant patient. The patient had no medical history. The patient did not receive any concomitant medications. On 29-Aug-2018, the patient (under age of 4 years) was administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right vastus lateralis (thigh), batch number: 252380 (reported as 255380) and expiry date: 31-May-2019). It was reported that, there were no complaints of any side effects. The reporter assessed the case as non-serious. Follow-up received from other health professional on 13-Sep-2018: Added route of administration: intramuscular, anatomical location: right vastus lateralis (thigh) and expiry date: 31-May-2019 of suspect vaccine in product tab. The reported batch number (255380) was added in narrative. The narrative was amended accordingly. Update received on 02-Oct-2018: Significant case correction (IRD: 13-Sep-2018): The batch number: 252380 was added in the product tab. The narrative was amended accordingly.
Gave patient a vaccine that expired 3/31/21.  Patient had left before could inform.  Called Vaers number but went to voicemail.
PATIENT COMPLAINED OF FEELING FLUSHED, ANXIOUS, AND SHAKY. PATIENT OBSERVED
On 5/18/08, about 24 hours after vaccine patient experienced tingling in face and legs, temp 100, seen at ER, thought to be possible reaction to preservative in the vaccine. Motrin was given. Patient's symptoms have resolved.
nausea; fatigue; muscle weakness; Inappropriate schedule of vaccine; Inappropriate schedule of vaccine; This case was reported by a nurse via call center representative and described the occurrence of nausea in a 17-year-old female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   Co-suspect products included Men ACWY-CRM NVS (Menveo) (batch number AMVA150A, expiry date 31st May 2020) for prophylaxis.   Previously administered products included Menveo (1st dose received on 31st July 2015).   On 15th July 2019, the patient received the 2nd dose of Menveo. On 16th August 2019, the patient received the 3rd dose of Menveo (intramuscular) .5 ml. On 15th July 2019, unknown after receiving Menveo and not applicable after receiving Menveo, the patient experienced extra dose administered. In August 2019, the patient experienced nausea, fatigue and muscle weakness. On 16th August 2019, the patient experienced extra dose administered. On an unknown date, the outcome of the nausea, fatigue and muscle weakness were not recovered/not resolved and the outcome of the extra dose administered and extra dose administered were unknown.   It was unknown if the reporter considered the nausea, fatigue and muscle weakness to be related to Menveo.  Additional details were provided as follows: The batch number of Menveo was updated as AMVA150A from AMAVA150A, as per sales data sheet. The nurse reported that, after 1st dose of Menveo, the patient received booster dose on 15th July 2019 and repeat dose on 16th August 2019, which led to extra dose administered. Less than a week after vaccination with 3rd dose, the patient experienced nausea, fatigue and muscle weakness. The reporter reported that, the patient still have symptoms.
headache, nauseous; taking Tylenol; feel the same as when the reaction started
Small cough started @ 2:00 p.m. By 3:30 I was feeling an illness coming on. Checked my temp.  101  and went to 102 by 6:00 p.m.  After taking Ibprofen fever went down to l01.  At l0:00 p.m. I took   Aleve.  Was very achey and had a sore throat all night...eyes very bloodshot and puffy in the morning.  Fever gone too.  Felt pretty normal as day wore on.
Myalgia, Palpitations, chills, slight headaches  Narrative: Received vaccine at 1000am and at 1100pm in the evening was woken up with a racing heartrate at 130 beats per minute. 3/1/21 developed chills,  body aches and tightness, and slight headaches. Is being seen in ER now 3/1/21 at 1500 to have kidney function checked and follow up on tachycardia. Reported.   Other Relevant History:
covid-19; covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 64-year-old male patient received BNT162b2 (Pfizer/BioNTech), on 02Apr2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 63 years, in left arm for COVID-19 immunization. The patient had no relevant medical history. The patient had no known allergies and no other medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "covid-19". The patient underwent the following laboratory tests and procedures: Covid-19 Test: Unknown Result. Therapeutic measures were taken as a result of drug ineffective, covid-19; used Paxlovid for COVID 19 Treatment from 17May2022 to 21May2022. It was also reported that the patient had rebound covid on 27May2022; recovering.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fever 99 to 100 (axillary), cranky, restless at night. Gave Tylenol every 3 to 4 hours. Tuesday, fever increased to 104 (axillary), woke up screaming. Gave Tylenol and fever decreased. Wednesday fever decreased throughout the day. Thursday took to doctor and MD recommended hospitalization to rule out kidney, etc. Saturday night she was discharged from the hospital and slowly improved. All test were (-). MD's all felt R/T Pertussis component of vaccine.
Hives; Swelling in the facial area; This spontaneous case was reported by a health care professional and describes the occurrence of URTICARIA (Hives) and SWELLING FACE (Swelling in the facial area) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives) and SWELLING FACE (Swelling in the facial area). At the time of the report, URTICARIA (Hives) and SWELLING FACE (Swelling in the facial area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.
severe blisters and bumps on hand and palms; severe blisters and bumps on hand and palms; painful due to blisters; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200326906 (Pfizer).  A 22 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Aug2021 17:00 (Batch/Lot number: unknown) at the age of 22 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (First Dose, Time: 12:00 PM, vaccine_location=Left arm), administration date: 16Jul2021, when the patient was 22 years old, for Covid-19 Immunization. The following information was reported: BLISTER (non-serious), SKIN LESION (non-serious) all with onset 07Aug2021 08:00, outcome "recovered" (14Aug2021) and all described as "severe blisters and bumps on hand and palms"; PAIN IN EXTREMITY (non-serious) with onset 07Aug2021 08:00, outcome "recovered" (Aug2021), described as "painful due to blisters". Therapeutic measures were not taken as a result of blister, skin lesion, pain in extremity.  Additional information: On 07Aug2021, the morning after the second dose of the vaccine, he noticed severe blisters and bumps on hand and palms. Due to the blisters, he was unable to freely flex or use his hands. Attempting to close his fist or move fingers was painful due to the blisters. This was worsened by hot weather. The blisters remained consistent until 11Aug, after which they faded away. As of 14Aug, they have no re-emerged. Patient not had any known allergies and not had any other medical history. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Patient not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination, patient not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
About 5 days following the shot, my skin began to itch and hives appeared. My hands and feet become itchy. Hives randomly appear all over my body.  I have been prescribed a steroid (Methylprednisolone) by my doctor. While I think it has helped, the hives are still appearing. This has now been going on for approximately 1.5 months.
Soreness of left arm extending to left side of neck; Tiredness /Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness of left arm extending to left side of neck) and FATIGUE (Tiredness /Fatigue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included ESTRADIOL (ESTROGEN), OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced PAIN (Soreness of left arm extending to left side of neck) and FATIGUE (Tiredness /Fatigue). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (Soreness of left arm extending to left side of neck) and FATIGUE (Tiredness /Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Blood pressure measurement: (High) BP high 5 hours after vaccine administration.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reported additional concomitant medications was muscle relaxant. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness of left arm extending to left side of neck) and FATIGUE (Tiredness /Fatigue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included ESTRADIOL (ESTROGEN), OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced PAIN (Soreness of left arm extending to left side of neck) and FATIGUE (Tiredness /Fatigue). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (Soreness of left arm extending to left side of neck) and FATIGUE (Tiredness /Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Blood pressure measurement: (High) BP high 5 hours after vaccine administration.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reported additional concomitant medications was muscle relaxant.
sore arm, throwing up, body pains, shaking, felt like he was going to pass out, impaired vision ( seeing purple and black spots)
16JUL98 started w/temp 102A, rash on face, head, neck, torso, arms, anorexic, fussy;
Information has been received from a physician concerning an 18 year old female patient who on an unspecified date was vaccinated IM 0.5ml with a first and second doses respectively of GARDASIL (lot numbers unspecified). The physician reported that the patient was given the first dose of the vaccine and the patient "got a little dizzy" (date unspecified). There was no adverse event after the patient got her second dose of the vaccine. At the time of the report the outcome of the patient was recovered (date unspecified). The patient sought unspecified medical attention. Additional information has been requested.
HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23; Patient received Moderna Bivalent vaccine after temperature excursion; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine after temperature excursion) and NO ADVERSE EVENT (No adverse event) in a 38-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 05D22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine after temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine after temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (HCP advised that her office administered vaccines that were reported being out of temperature on 2-24-23) and POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine after temperature excursion).    Patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-730480 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-730480:Same reporter
Headache, Body aches, Fatigue, then chills on and off overnight, slight fever just over 101, mildly nauseous, just felt like I had the flu. The Shot was given at my 11 am appointment on Wednesday, November 10th.  Into the evening, I started feeling really cold and not feeling well. Overnight, I had the chills on and off, my temp around 8 am was at 101.7,and I just felt miserable.   I never notified my doctor. I chose to ride out the symptoms and took a day off of work and stayed in bed. I still have a mild headache on and off, and the shot site still hurts, though not as bad as it did for the first two days after I got the shot.
Seen at PCP office on 09/04/14 with erythema extending to 11x15 cm on upper L arm, vesicles around injection site measuring 3.5cm x 3cm in total with one large bullar measure 12 mm x 14 mm. No shortness of breath, no throat closing, no itching of throat.
THE PATIENT  WAS TESTED FOR COVID ON 7/21/2021 THE RESULT CAME POSITIVE
12/30/03-extreme fatigue, 1/1/04 muscle weakness, 1/4-5/04-N/V, 1/3 HA, seeing double, 1/5-6/04 progressive weakness 1st hands then feet, hospitalized 1/6/04. Ptosis of R eye. Miller Fisher variant of Guillain Barre syndrome. The medical records received on 1/20/04 states URI, diplopia, ataxia, numbness, neck weak, absent refleses, and lethargy. 60-day follow up on 04/21/04: "Pt has not recovered from adverse event. Still recovering as of 04/08/04. Decreased stamina, persisting double vision, weakness in arms and legs." Per annual report- Per MD check-up, patient has recovered 45% of strength.  Patient has tingling sensation on hands.  No longer has double vision.
On 2JUN91 pt devel fever, cold, t101.4, Seen by ER MD;3JUN91 taken to pvt MD w/sz; tx ATB; 3JUN91 t96.8 ax; Sz 5 days following vax; no tx given 2JUN91 mom witnessed;
Approx 1 inch oval swelling left thigh hematoma, vaccines given 05/23/2005 reported to us 10/07/2005. Referred to general surgery ultrasound ordered. 12/1/05 Review of medical record indicates final diagnosis of sterile abscess.  12/14/05 Discharge Summary/Operative report received. Diagnosis was L thigh abscess.
neurological reactions with jerking of his head; eyes rolling back; weird ticking habit; shrugging movements and opening mouth; Initial information was received on 31-Aug-2020 regarding an unsolicited valid serious case from a consumer/non-health care professional.  This case involves a 5-year-old male patient who had neurological reactions with jerking of his head (dyskinesia), eyes rolling back (eye movement disorder), weird ticking habit (tic), shrugging movements and opening mouth (movement disorder) while he received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  Medical history, medical treatment(s), vaccination(s), and family history were not provided.  The patient had not received any concomitant vaccination that day.  On an unknown date in Dec-2019, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UT6695LA, expiry date 30-Jun-2020) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a neurological reactions with jerking of his head (dyskinesia), eyes were rolling back (eye movement disorder) and had a weird ticking habit (tic) within a few days following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Dyskinesia was assessed as medically significant and rest events were assessed as non-serious.  On an unknown date, the patient had more shrugging movements and opening mouth (movement disorder) (unknown latency) (non-serious event) following the administration of INFLUENZA QUADRIVAL A-B VACCINE The patient was seen by a pediatrician as his mother thought he had an allergic reaction. He did not have any reactions like rash.  No laboratory data was provided.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event dyskinesia, eye movement disorder and movement disorder was unknown while the patient was recovering from tic by the end of Apr-2020.; Sender's Comments: This case concerns a 5 year old male patient who had dyskinesia, eye movement disorder and movement disorder within few days after vaccination with INFLUENZA INFLUENZA QUADRIVAL A-B VACCINE. He had tic (unknown latency) after vaccination with INFLUENZA QUADRIVAL A-B VACCINE. The time to onset is compatible for events dyskinesia, eye movement disorder and movement disorder. Additional information regarding medical history, condition at the time of vaccination and lab data excluding other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
RN gave undiluted Pfizer to patient- the whole vial (6 doses)
Rt leg localized redness/swelling immed. after PENTACEL and Hep B administration. Applied cold pack to area. TYLENOL admin for comfort.
Chills; Experienced mild flu like symptoms; Fever; This is a spontaneous report from a non-contactable physician (patient).  A 31 year old female patient (physician) received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on19Dec2020 as a single dose for COVID-19 vaccination. Medical History was reported as none. There were no concomitant medications. On Dec2020, the patient experienced chills, mild flu like symptoms and fever. In Dec2020, she was now fully recovered. The clinical outcome of chills, mild flu like symptoms and fever was recovered Dec2020  No follow-up attempts are possible; information about lot number cannot be obtained.
Extreme swelling and redness at injection site about softball sized area, sore throat, chills, nausea, achiness, flu-like symptoms, sore shoulder joint, hard to move shoulder (left).
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with expired dose of GARDASIL 9 (lot # L014415, expiration date: 25-JUL-2017) intramuscularly for prophylaxis. There was no adverse effects reported.
My family had all 3 doses as early as we could get them; however, we now ALL have COVID; My family had all 3 doses as early as we could get them; however, we now ALL have COVID; My family had all 3 doses as early as we could get them; however, we now ALL have COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant), DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "My family had all 3 doses as early as we could get them; however, we now ALL have COVID". Additional information: "The web site states " Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers" My family had all 3 doses as early as we could get them; however, we now ALL have COVID. Not surprisingly, new strains are different enough to get past this immunity. The 2021-2022 flu vaccine is out, where is the updated COMIRNATY vaccine"  The lot number for bnt162b2 was not provided and will be requested during follow up.
Severe (R) shoulder pain within 12hrs of receiving PNEUMOVAX 23 pt had a large area of redness & swelling.